Biosino Suzhou Medical Instrument Co., Ltd announced that it will raise CNY 20 million in a round of funding on August 17, 2023. The transaction included participation from new investors, Biosino Bio-Technology and Science Incorporation, Beijing Chenyimeng, China Technology Industry Group Limited, Hefei Tashi for CNY 5 million, Hefei Xiangpeng for CNY 5 million. The transaction has been approved by shareholder of the company.
Biosino Bio-Technology and Science Incorporation
Equities
8247
CNE100000288
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9 HKD | 0.00% | 0.00% | +12.50% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
0.9 HKD | 0.00% | 0.00% | 16.67M | ||
0.08 HKD | 0.00% | 0.00% | 4.72M | ||
1st Jan change | Capi. | |
---|---|---|
+12.50% | 16.67M | |
-3.63% | 12.18B | |
+7.68% | 5.96B | |
+26.94% | 5.45B | |
-5.09% | 4.34B | |
-52.54% | 3.18B | |
+14.18% | 2.75B | |
+32.50% | 2.3B | |
-3.65% | 2.28B | |
-1.69% | 1.92B |
- Stock Market
- Equities
- 8247 Stock
- News Biosino Bio-Technology and Science Incorporation
- Biosino Suzhou Medical Instrument Co., Ltd announced that it expects to receive CNY 20 million in funding from Biosino Bio-Technology and Science Incorporation, Beijing Chenyimeng Technology Co., Ltd., China Technology Industry Group Limited, Hefei Tashi, Hefei Xiangpeng Technology Service Partnership (Limited Partnership)